Linagliptin for the elderly (or Who moved my Lancet?)
Category: Big Pharma, Blog, diabetes, elderly, K.O.L. Líder de Opinión, linagliptin, The Lancet, Type 2 diabetes
Some weeks ago I was writing that my Lancet had changed. Somebody had exerted a kind of evil influence or so. I couldn’t recognize him; he was ill. And I told to myself: “well, maybe he’s got a fever, leave him recover himself in peace…”Very recently, October 26th, The Lancet was publishing a phase III Clinical Trial dealin’ ’bout linagliptin in the elderly. I hereby invite everybody to think ’bout the issue, and to throw my writings
